Exclusive Content
Lupin Announces U.S. FDA Approval and Launch of Sugammadex Injection
Lupin Limited announced that it has received approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application (ANDA)...
WHO Introduces Shorter Treatment Options for Kala-azar and PKDL
World Health Organization has released a major revision of its clinical guidance for treating visceral leishmaniasis (commonly known as kala-azar) and post-kala-azar dermal leishmaniasis (PKDL), aiming to ease...
First-Ever Freeze-Dried Plasma Secures FDA Approval for Emergency Use in the U.S.
The U.S. Food and Drug Administration has granted its first-ever license for a freeze-dried plasma product, marking a major advance in emergency transfusion medicine....
FSSAI Suspends License of Dior Pharmaceuticals Over Critical Violations at Nutraceutical Manufacturing Unit
The Food Safety and Standards Authority of India (FSSAI) has officially suspended the manufacturing license of Dior Pharmaceuticals with immediate effect, following a comprehensive...
JP Nadda Urges Bengal MPs to Join the Fight Against TB
Union Health Minister J.P. Naddamet with West Bengal's Members of Parliament in New Delhi on Wednesday, urging cross-party lawmakers to spearhead grassroots efforts against tuberculosis...
AstraZeneca reports Mixed Phase III Results for Ultomiris in Rare Post-Transplant Blood Disorder
AstraZeneca's Alexion unit has reported divergent outcomes from its late-stage program testing Ultomiris (ravulizumab) in patients with thrombotic microangiopathy following hematopoietic stem cell transplant (HSCT-TMA), a rare and...
